(Q34462070)

2 August 2017

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke (English)

1 reference

2 August 2017

1 reference

M Gent

1

1 reference

2 August 2017

J A Blakely

2

1 reference

2 August 2017

J D Easton

3

1 reference

2 August 2017

D J Ellis

4

1 reference

2 August 2017

V C Hachinski

5

1 reference

2 August 2017

J W Harbison

6

1 reference

2 August 2017

E Panak

7

1 reference

2 August 2017

R S Roberts

8

1 reference

2 August 2017

J Sicurella

9

1 reference

2 August 2017

A G Turpie

10

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

1215-1220

1 reference

2 August 2017

8649

1 reference

Survival and recurrence following stroke. The Framingham study.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Single studies and overview analyses: is aspirin of value in cerebral ischemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

The mechanisms of action of ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Designs for group sequential tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Controlled trial of aspirin in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Controlled trial of aspirin in cerebral ischemia. Part II: surgical group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

A randomized trial of aspirin and sulfinpyrazone in patients with TIA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Controlled Trial of Dipyridamole in Cerebral Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

Controversy in Counting and Attributing Events in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992327-1

7 January 2021

10.1016/S0140-6736(89)92327-1

Identifiers

DOI

1 reference

2 August 2017

1 reference